Aggarwal C, Saba NF, Algazi A, Sukari A, et al. Safety and Efficacy of MEDI0457 Plus Durvalumab in Patients With Human Papillomavirus-associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 2022 Dec 1:CCR-22-1987. doi: 10.1158/1078-0432.CCR-22-1987.
PMID: 36455147